echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Use of the Dizziness/Vertigo Scale, Super-Comprehensive

    Use of the Dizziness/Vertigo Scale, Super-Comprehensive

    • Last Update: 2022-03-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    *Only for medical professionals to read and reference Quick Collection! Dizziness/vertigo has various manifestations.
    It is a subjective feeling.
    In clinical practice, we need to use scales to change the subjective description of experience into quantitative analysis, which can objectively and quantitatively evaluate the clinical conditions of different patients, which is beneficial to different patients, Objective comparisons between vertigo medical centers or different studies can provide good clues for clinical decision-making
    .

    At the 13th Annual Meeting of Neurological Physicians of the Chinese Medical Doctor Association, Professor Ju Yi from the Neurology Center of Beijing Tiantan Hospital Affiliated to Capital Medical University made a wonderful report on the topic "Use of Dizziness/Vertigo Scale"
    .

    Currently commonly used dizziness/vertigo-related scales include assessment of vertigo severity, assessment of disability or quality of life in patients with vertigo, comprehensive assessment of vertigo, assessment of vertigo combined with mental and psychological disorders, assessment of fall risk in patients with dizziness, and diagnosis of vestibular disease.
    The professor summarizes these scales and their research progress as follows
    .

    01 Evaluation of the severity of vertigo 1.
    Vertigo Symptom Scale (VSS) This table has many clinical applications
    .

    In 1992, it was first used to assess the degree of vertigo in 127 vertigo patients by Yardley et al
    .

    Applicable to patients' self-assessment of the severity and frequency of vertigo within 1 year
    .

    The VSS is a questionnaire with predictive validity, with higher baseline autonomic and somatic symptom scores predicting higher prevalence after 7 months
    .

    The VSS includes the Vertigo Subscale (VSS-VER), which assesses symptoms associated with vestibular disorders, and the Anxiety and Autonomic Symptoms Subscale (VSS-AA), which assesses symptoms caused by autonomic or somatic anxiety.
    symptoms
    .

    (The Chinese version of the scale has a total of 34 items, each with a score of 0-4, and the score indicates the frequency.
    The higher the total score, the more severe the degree of vertigo
    .

    0-33 is for mild vertigo, 34-67 is for moderate vertigo, 68 -101 is divided into severe vertigo, 102-136 is divided into very severe vertigo) Application: The patient fills in the VSS scale to help determine the relationship between dizziness and anxiety
    .

    Combined with other scales (eg DHI) to assess dizziness/vertigo treatment effects (acupuncture, vestibular rehabilitation, drugs, surgery, etc.
    )
    .

    Insufficiency: Common complaints of patients with peripheral vestibular disease and VSS items do not cover each other
    .

    VSS is not suitable for differentiating peripheral vestibular disorders
    .

    2.
    The European Vertigo Assessment Scale (EEV) was proposed in 2011 to assess vestibular symptoms
    .

    It belongs to the other scale and only evaluates the symptoms of vestibular syndrome, including motor illusion, duration, exercise intolerance, autonomic signs and instability
    .

    The items included in the EEV were related to the intensity, number and duration of vertigo episodes, especially the number of episodes
    .

    There is currently no Chinese version
    .

    Introduction: EEV has good test-retest validity (except for items related to physical nerve signs)
    .

    Test-retest validity, inter-rater consistency, and inter-rater reliability are good, which can effectively monitor the process of vertigo and evaluate the effect of anti-vertigo treatment
    .

    It can be used alone or in combination with other scales
    .

    3.
    Visual Analog Scale (VAS) method: 0 points means no dizziness, 10 points means extreme dizziness or avoidance of activities due to dizziness
    .

    Advantages: Simple and easy to understand, can avoid language barriers and comprehension difficulties, suitable for large medical centers with diverse populations
    .

    Application: To assess the severity of vertigo before and after treatment
    .

    To assess the efficacy of vertigo treatment options
    .

    Evaluation of residual symptoms after reduction in benign paroxysmal positional vertigo (BPPV)
    .

    02 Assessment of disability or quality of life in patients with vertigo 1.
    Dizziness Disability Rating Scale (DHI) This scale is widely used at home and abroad
    .

    A total index (DHI-T) and 3 sub-indexes can be calculated: functional (DHI-F), affective (DHI-E) and somatic (DHI-P)
    .

    In clinical research, DHI is often used for patients' self-assessed living disability caused by vertigo symptoms
    .

    (The original DHI contains 25 questions, each with 3 options: yes 4, sometimes 2, no 0.

    The
    overall index DHI-T (0-100) assesses the severity of vertigo symptoms as a whole: 0-30 is mild abnormality, 30-60 is moderate abnormality, >60 is severe abnormality and there is a risk of falling)
    .

    Advantages: Good responsiveness in patients with dizziness, vertigo, and instability
    .

    was positively correlated with VAS
    .

    In clinical research, DHI is often used for patients' self-assessed living disability caused by vertigo symptoms
    .

    Has good psychometric properties
    .

    High test-retest reliability, good internal consistency, reliability, and responsiveness
    .

    Age, diagnosis (undiagnosed; episodic, acute, or chronic vestibular syndrome), and symptoms did not significantly affect DHI scores
    .

    Deficiencies: Otologic symptoms (hearing loss, ear fullness) and autonomic symptoms (nausea, vomiting) are excluded, as these are common concomitant symptoms of vestibular disorders
    .

    Self-care is also an important part of daily activities, but the DHI did not assess the impact of dizziness on patient self-care
    .

    Scope of application (used in previous clinical studies): assessment of patients with dizziness outpatient balance problems; assessment of the degree of disability in patients with dizziness; evaluation of the effect of vestibular disease treatment and selection of treatment options, such as evaluation of residual symptoms after BPPV reduction and vestibular Quality of life assessment in patients with paroxysmal disease after drug therapy
    .

    2.
    The Vestibular Disorders of Daily Living Scale (VADL) was originally used by vestibular rehabilitation therapists to assess patients and formulate treatment plans
    .

    The current version is adapted from the responses of patients undergoing vestibular rehabilitation to accurately reflect the patient's experience and understand the patient's level of disability in a particular activity or task
    .

    Used to assess the impact of impaired vestibular function on daily living, including functioning (self-care and intimate activities), ambulation (walking and going up and down stairs), and tools (home management and recreational activities)
    .

    (There are 28 items in the scale, divided into 3 areas
    .

    The current version is a 10-point scale, which can accurately reflect the patient's experience and understand the degree of disability of the patient in a specific activity or task) Application (used in previous studies): Evaluation of chronic dizziness Changes before and after the patient's recovery
    .

    Therapeutic effect in patients with vestibular neuritis or labyrinthitis
    .

    Evaluation of canal stone reduction and release therapy in patients with BPPV
    .

    Evaluation of pharmacotherapy in patients with familial episodic disorders
    .

    Weaknesses: Inability to distinguish specific disease diagnoses
    .

    Unable to differentiate BPPV from chronic vestibular disorders
    .

    Content and terminology are not specific to vertigo
    .

    3.
    The Vertigo Disability Questionnaire (VHQ) is a tool to assess the physical and psychological effects of perceptual impairment and therapeutic intervention in patients with vertigo
    .

    There is no Chinese version of the self-assessment questionnaire
    .

    The assessment time is 10-15 minutes
    .

    The age range of use is 18-64 years old and the elderly over 65 years old
    .

    To assess the impact of vertigo on quality of life
    .

    Four dimensions of vertigo impact were measured: activity limitation, social anxiety, fear of vertigo, and seizure severity
    .

    There are 25 items in total, with 0-4 points for each item, with a total score of 100 points
    .

    Assessments included activities of daily living, participation in activities, social relationships, social support, quality of life, and vestibular symptoms
    .

    The total score was independent of patient age, gender, and time of vertigo onset, but correlated with diagnostic category
    .

    The results showed that the greatest distress in peripheral vestibular patients was discontinuation of activity due to dizziness
    .

    The number of patients currently used to assess VHQ responsiveness is limited, and its psychological properties require further confirmation
    .

    03 Vertigo Comprehensive Assessment 1.
    The Vertigo, Dizziness and Lability Questionnaire (VDL) assesses the sensory and psychosocial consequences of dizziness/lability
    .

    Divided into two parts: symptom scale (VDI-SS) and quality of life scale (VDI-HRQoL)
    .

    The questionnaire contains 15 questions, with a total score ranging from 0 to 100.
    The higher the score, the greater the impact of dizziness on the patient's life.
    The score for each question ranges from 0 to 4, with a good score of 4 and a poor score of 0
    .

    The scale has high reliability and high internal consistency
    .

    At present, there is no Chinese scale, and the adaptation in the Chinese population deserves further study
    .

    2.
    The University of California, Los Angeles Dizziness Questionnaire (UCLA-DQ) was developed by five physicians and researchers from the University's head and neck surgery department and tested in patients with vestibular disorders
    .

    It was first published in the American Journal of Otology in 1996
    .

    The five-item scale assesses the frequency and intensity of dizziness symptoms, the impact of dizziness on daily activities and quality of life, and the level of fear of dizziness attacks
    .

    UCLA-DQ is concise, easy to manage and understand, suitable for patients with various types of vertigo, can be quickly applied to a large number of patients, and is easy to analyze statistically
    .

    04 Evaluation of Vertigo Complicated with Psychiatric Disorders 1.
    Hospital Anxiety and Depression Scale (HADS) This table was designed by Zigmond and Snaith more than 30 years ago
    .

    The biggest advantage is that it is simple, fast and convenient.
    It can assess anxiety and depression at the same time, and the assessment can be completed in 2-5 minutes
    .

    HADS has 7 questions each on anxiety and depression, which are interspersed in the questionnaire and need to be counted separately
    .

    Advantages: Simple, fast and convenient, the assessment can be completed in 2-5 minutes
    .

    It is a confirmed screening tool in patients with dizziness, and is recommended for evaluation and screening of mental disorders in patients with dizziness
    .

    HADS anxiety index ≥ 8, or depression index t> 8, or the sum of the two indices ≥ 12, indicating significant clinical psychiatric symptoms, and its sensitivity to predict positive psychiatric disorders is 92%
    .

    Weaknesses: The meta-analysis shows that the underlying structure of HADS is unclear and cannot be used to distinguish anxiety from depression, so it can only be used for general screening in the two main areas of mental illness in patients with dizziness
    .

    HADS is no better than other screening tools at identifying specific affective disorders
    .

    The reliability and validity of the Chinese version of the HADS scale have been verified in patients with cardiovascular disease, inpatients and physical examination centers, but have not been extended to patients with dizziness/vertigo
    .

    2.
    Hamilton Anxiety/Depression Scale The Hamilton Anxiety Scale (HAM-A) was developed in 1959 and is one of the scales used to assess the severity of anxiety symptoms.
    It is a clinician-based questionnaire and can also be used as a self-rating scale.
    table
    .

    Previous studies: The HAM-A scale can be used in conjunction with the State-Trait Anxiety Questionnaire and the Baker Depression Scale to assess vestibular migraine, migraine, and anxiety in healthy individuals
    .

    The Hamilton Rating Scale for Depression (HRSD, HDRS, or Ham-D) is a scale used to assess the effects of first-generation antidepressants and is currently widely used to evaluate antidepressants in clinical trials
    .

    3.
    The State-Trait Anxiety Inventory (STAI) self-assessed the severity of existing anxiety symptoms and the tendency to anxiety
    .

    It includes 2 subscales: the State Anxiety Inventory (STAI-E) and the Trait Anxiety Inventory (STAI-T), the former assesses the patient's existing anxiety state, and the latter assesses the inherent aspects of "anxiety tendencies"
    .

    Higher scores indicate greater anxiety
    .

    05 Assessment of fall risk in patients with dizziness 1.
    Activity-specific Balance Confidence Scale (ABC) ABC is an assessment tool for peripheral vestibular disorders, which is used to assess the subjective balance confidence of community-based elderly
    .

    The table has good internal consistency and 2-week test-retest reliability, and can effectively and sensitively test the changes of balance confidence in patients with unilateral peripheral vestibular disorder
    .

    2.
    The Efficacy of Falls Scale International (FES-I) is mainly used to assess the fear of falls in the elderly
    .

    06 Diagnosis of vestibular disorders 1.
    The American Dizziness Diagnostic Scale (ADDS) is used to assess and differentially diagnose vestibular disorders
    .

    The scale is divided into 5 parts: general information, peripheral vestibular dysfunction, content related to BPPV, content related to central disease, and duration of dizziness
    .

    The table has high sensitivity and specificity, reaching 96%, so ADDS is recommended as a first-line assessment tool in general outpatient clinics, which can initially identify vestibular diseases
    .

    2.
    Meniere's Disease Severity Index (MD-POSI) includes four aspects: symptoms and functional status at the onset, symptoms and functional status between attacks, the impact of daily activities during the disease, and the impact of the disease on work
    .

    The table has good validity and internal consistency
    .

    3.
    Dokuz Eylul University Meniere's Disease Disability Scale, DEUMDDS This scale is used to evaluate the quality of life of MD patients, including 2 subscales: "acute attack period" and "interictal period"
    .

    There was a significant correlation with DHI-T
    .

    Not related to vestibular testing, age or gender
    .

    Summary: 1.
    The dizziness/vertigo scale can change the subjective description of experience into a quantitative description, and can objectively and quantitatively evaluate the clinical conditions of different patients, which is conducive to the objective comparison of different patients, vertigo medical centers or different studies, and guides clinical decision-making
    .

    2.
    A single scale cannot describe the comprehensive content of vertigo diseases.
    It is necessary to understand the performance and structure of commonly used vertigo scales, and to choose vertigo scales or questionnaires appropriately
    .

    3.
    When choosing a scale, attention should be paid to the scope of application, advantages and disadvantages, reliability and validity of each scale, and an appropriate scale should be selected in combination with the patient population and research objectives
    .

    Source of this article: Neurology Channel of the Medical Community Author of this article: CNA Report Team Review of this article: Ju Yi, Beijing Tiantan Hospital Affiliated to Capital Medical University Editor in charge: Mr.
    Lu Li The timeliness of the content, and the accuracy and completeness of the cited materials (if any), etc.
    make any commitments and guarantees, and do not assume any responsibility for the outdated contents, the possible inaccuracy or incompleteness of the cited materials.
    any liability
    .

    Relevant parties are requested to check separately when adopting or using it as a basis for decision-making
    .

    Contribution/reprint/business cooperation: yxjsjbx@yxj.
    org.
    cn
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.